You are here

Biblio

Search

Show only items where

Author

Type

Term

Year

Keyword

Export 12 results:

Author Title Type [ Year

]

Filters: Author is Lopez, Oscar L and First Letter Of Title is C [Clear All Filters]

2007

Carmichael OT, Kuller LH, Lopez OL, Thompson PM, Dutton RA, Lu A, Lee SE, Lee JY, Aizenstein HJ, Meltzer CC, et al. Cerebral ventricular changes associated with transitions between normal cognitive function, mild cognitive impairment, and dementia. Alzheimer Dis Assoc Disord. 2007 ;21(1):14-24.

2010

Barnes DE, Covinsky KE, Whitmer RA, Kuller LH, Lopez OL, Yaffe K. Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." Dementia risk indices: A framework for identifying individuals with a high dementia risk. Alzheimers Dement. 2010 ;6(2):138-41.

2012

Rajagopalan P, Jahanshad N, Stein JL, Hua X, Madsen SK, Kohannim O, Hibar DP, Toga AW, Jack CR, Saykin AJ, et al. Common folate gene variant, MTHFR C677T, is associated with brain structure in two independent cohorts of people with mild cognitive impairment. Neuroimage Clin. 2012 ;1(1):179-87.

2017

Kuźma E, Airdrie J, Littlejohns TJ, Lourida I, Thompson-Coon J, Lang IA, Scrobotovici M, Thacker EL, Fitzpatrick A, Kuller LH, et al. Coronary Artery Bypass Graft Surgery and Dementia Risk in the Cardiovascular Health Study. Alzheimer Dis Assoc Disord. 2017 .

2020

Duan W, Sehrawat P, Balachandrasekaran A, Bhumkar AB, Boraste PB, Becker JT, Kuller LH, Lopez OL, H Gach M, Dai W. Cerebral Blood Flow Is Associated with Diagnostic Class and Cognitive Decline in Alzheimer's Disease. J Alzheimers Dis. 2020 ;76(3):1103-1120.

2021

Miller LM, Wu C, Hirsch CH, Lopez OL, Cushman M, Odden MC. Cardiovascular damage phenotypes and all-cause and CVD mortality in older adults. Ann Epidemiol. 2021 ;63:35-40.

Duan W, Zhou GD, Balachandrasekaran A, Bhumkar AB, Boraste PB, Becker JT, Kuller LH, Lopez OL, H Gach M, Dai W. Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer's Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study. J Alzheimers Dis. 2021 ;82(1):293-305.

2023

Bouzid H, Belk JA, Jan M, Qi Y, Sarnowski C, Wirth S, Ma L, Chrostek MR, Ahmad H, Nachun D, et al. Clonal hematopoiesis is associated with protection from Alzheimer's disease. Nat Med. 2023 ;29(7):1662-1670.

Huque MHamidul, Kootar S, Eramudugolla R, S Han D, Carlson MC, Lopez OL, Bennett DA, Peters R, Anstey KJ. CogDrisk, ANU-ADRI, CAIDE, and LIBRA Risk Scores for Estimating Dementia Risk. JAMA Netw Open. 2023 ;6(8):e2331460.

2024

Gutierrez-Tordera L, Moseholm KF, Trius-Soler M, Bulló M, Fitzpatrick A, Connelly MA, Lopez OL, Jensen MK, Guasch-Ferré M, Mukamal KJ. Circulating Ketone Bodies, Pyruvate, and Citrate and Risk of Cognitive Decline, Structural Brain Abnormalities, and Dementia. Aging Dis. 2024 .

Moseholm KF, Horn JW, Fitzpatrick AL, Djoussé L, Longstreth WT, Lopez OL, Hoofnagle AN, Jensen MK, Lemaitre RN, Mukamal KJ. Circulating sphingolipids and subclinical brain pathology: the cardiovascular health study. Front Neurol. 2024 ;15:1385623.

Moseholm KF, Cronjé HT, Koch M, Fitzpatrick AL, Lopez OL, Otto MC de Olive, Longstreth WT, Hoofnagle AN, Mukamal KJ, Lemaitre RN, et al. Circulating sphingolipids in relation to cognitive decline and incident dementia: The Cardiovascular Health Study. Alzheimers Dement (Amst). 2024 ;16(3):e12623.